←
JU Open Plus396 posts
JU Open Plus avatar✓

JU Open Plus ✓

@JUOpenPlus

Official journal of @Amerurological. Your source for open access urology research: original studies, reviews, videos & more. Submit, read, share!

◷ Joined February 2022▧ 365 Photos and videos
JU Open Plus avatar
JU Open Plus@JUOpenPlus·Nov 16

🔍 Are ePROs Just Another Survey? An editorial explores sociodemographic barriers to ePROs like WISQOL and highlights areas for improvement. 🧪 Evidence - High social vulnerability reduces ePRO participation ⚠️ Caution - Don't underestimate sociodemographic factors 💡 Impact - Insights could refine ePRO designs and equity Read more: bit.ly/4AsOcen

Post attachment
JU Open Plus avatar
JU Open Plus@JUOpenPlus·Nov 12

🔍 Comparing Surgical Options for Vesicoureteral Reflux This study evaluates the risks and outcomes of laparoscopic vs. open surgery for vesicoureteral reflux in a Japanese multicenter cohort. 🔧 Longer Surgery - Laparoscopic takes 262 min vs. 182 min for open 🏥 Faster Recovery - Earlier catheter removal (3 vs. 6 days) with laparoscopic ⚠️ Higher Risk - Laparoscopic has more complications and reoperations tnyp.me/mdymEwdU/x

Post attachment
JU Open Plus avatar
JU Open Plus@JUOpenPlus·Nov 12

We're excited to welcome Marisa M. Clifton, MD, FACS as our incoming editor. Dr. Clifton has helped shape the journal's success as an associate editor, and we look forward to working together to continue advancing rigorous, impactful and accessible urologic scholarship for the global community.

Post attachmentPost attachment
JU Open Plus avatar
JU Open Plus@JUOpenPlus·Nov 5

📖 The October issue of the Journal of Urology Open Plus is now available! This month explores the power of collaboration, innovation and patient-centered care, featuring research on AI-assisted microsurgery, prostate cancer outcomes, vesicoureteral reflux treatment, early-onset bladder cancer and more. Plus, editorial perspectives examine emerging topics ranging from health information-seeking behavior to improving patient-reported outcomes. Dive into the latest research shaping the future of urology! tnyp.me/OLUpTOOy/x

0:05
JU Open Plus avatar
JU Open Plus@JUOpenPlus·Nov 4

🚨 Why Are Patients Returning to the ED after Urologic Surgery? A study examined unplanned ED visits within 7 days post-outpatient urologic surgery and their impact on patient care. 🔍 Key Findings 3.4% of surgeries led to ED visits. Most visits were due to fever/sepsis (21%) or urinary retention (16%). Only 34.5% contacted their urology service first. 🚑 Implications Enhanced monitoring and interventions may reduce ED visits and improve outcomes. #Urology #HealthCare #PatientCare tnyp.me/ExDMBJLt/x

Post attachment
JU Open Plus avatar
JU Open Plus@JUOpenPlus·Nov 4

🔍 Can Micro-Ultrasound Sagittal Length Improve Prostate Cancer Predictions? A study investigates using micro-ultrasound sagittal lesion length to better predict significant prostate cancer in high-risk patients. 🔢 Threshold Accuracy - A 2.1 cm length boosts PPV to 91.6% 📈 Predictive Increase - Each cm increase raises cancer odds by 8.7% 📉 Limitations - Length not independent predictor after adjustments #ProstateCancer #MicroUltrasound #Imaging tnyp.me/4o5Oxzgb/x

Post attachment
JU Open Plus avatar
JU Open Plus@JUOpenPlus·Nov 3

🔍 Can We Improve Bladder Cancer Care? A study examines optimal care coordination for #LocalizedBladderCancer in the US, revealing critical barriers and solutions for better outcomes. 👥 Multidisciplinary Collaboration - Essential for effective BC management 🔗 Coordination - Key to overcoming care fragmentation 📚 New Recommendations - 10 strategies to enhance care quality tnyp.me/i3OZzugL/x

Post attachment
JU Open Plus avatar
JU Open Plus@JUOpenPlus·Nov 1

🔬 Can Early-Onset Bladder Cancer Hold the Key to New Treatments? A recent study profiles the genetic landscape of early-onset bladder cancer, identifying key mutations that could guide personalized therapies. 🧬 Distinct Mutations - Younger patients show high TP53 (83%) and FGFR3 (45%) mutation rates, highlighting unique pathways. 🎯 Potential Targets - Findings suggest FGFR3 mutations as actionable therapeutic opportunities in young patients. 🚹 Demographic Insights - Predominantly male cohort with lower smoking rates compared to older counterparts. #BladderCancer #Genomics #PrecisionMedicine tnyp.me/TohgPQEI/x

Post attachment
JU Open Plus avatar
JU Open Plus@JUOpenPlus·Oct 30

🩺 Can Salvage MDT Manage Prostate Cancer Without ADT? A #trial examines if metastasis-directed therapy (MDT) without androgen deprivation can effectively treat oligorecurrent prostate cancer #PCa. 🔍 Detection - PET scans underreport nodal disease 🙅‍♂️ Feasibility - MDT sans ADT is safe and feasible 📉 Response - 40% saw ≥50% PSA drop by 6 months tnyp.me/AvXPOb1B/x

Post attachment
JU Open Plus avatar
JU Open Plus@JUOpenPlus·Oct 28

🔍 Do Sociodemographic Factors Affect ePRO Completion? This study investigates the impact of social and demographic factors on the completion of electronic Wisconsin Stone Quality-of-Life (WISQOL) surveys by nephrolithiasis patients. 📉 Low Completion Rate - Only 23.4% of distributed ePROs were fully completed 👵 Older is Better - Older white non-Latinx patients had higher completion rates 🔗 Social Vulnerability - High SVI linked to lower completion and poorer quality of life scores #Urology #PublicHealth #ePRO #HealthDisparities tnyp.me/NRJ5cGPb/x

Post attachment
JU Open Plus avatar
JU Open Plus@JUOpenPlus·Oct 26

🔍 Validating Sexual Health Assessments for MSM with Prostate Cancer A new study validates a novel questionnaire for assessing the sexual quality of life in men who have sex with men (MSM) with prostate cancer (PCa). 📋 13 Domains: Covers diverse sexual practices and concerns unique to MSM 🔄 Reliable Data: Strong test/retest reliability in most domains 🚻 Treatment Impact: Radical prostatectomy linked to worse urinary issues than radiation #ProstateCancer #SexualHealth #MSM #CancerResearch tnyp.me/DZULzpco/x

Post attachment
JU Open Plus avatar
JU Open Plus@JUOpenPlus·Oct 22

🔍 Navigating Prostate Cancer Decisions An editorial highlights a new tool to support patient-centered treatment choices in localized prostate cancer care. 🧪 Evidence - Considers financial and medical toxicity for informed decisions ⚠️ Caution - Avoid broad application of new therapy data 💡 Impact - Guides future decision-making tool development #ProstateCancer #PatientCare #Innovation tnyp.me/N6dKiGGd/x

Post attachment
JU Open Plus avatar
JU Open Plus@JUOpenPlus·Sep 24

🔬 Self-Administering Bladder Treatments: A New Frontier? A study examines patient perspectives on self-administered intravesical therapy for Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS). 🕒 Time Saver - Self-administering saves time vs. office visits 🏡 Autonomy Boost - Increases patient control over their treatment 💬 Concerns - Fear of improper self-administration holds some back #ICBPS #PatientCenteredCare DOI: tnyp.me/tUFddbtt/x

Post attachment
JU Open Plus avatar
JU Open Plus@JUOpenPlus·Sep 22

💉 Bulkamid Injections for Urinary Incontinence: What Do the Numbers Say? A study reviews the reintervention rates of Bulkamid for SUI, highlighting its impact on symptom improvement. 📉 Reinterventions - 35.7% needed multiple injections 🔄 Symptom Relief - 65.2% reported better outcomes post-injection 💊 Comorbid Impact - Mixed incontinence improved more than pure SUI #UrinaryIncontinence #Bulkamid #SUI tnyp.me/wSWwCUPx/x

Post attachment
JU Open Plus avatar
JU Open Plus@JUOpenPlus·Sep 16

🚀 Are Urologists Shaping Prostate Cancer Treatment? A study examines variations in how urologists intensify androgen deprivation therapy in metastatic hormone-sensitive prostate cancer patients. 🔍 Practice Variations - Significant differences found in treatment intensification among urologists 📈 Rising Trends - Intensification surged from 6% (2014) to 59% (2022) 🔬 Patient Factors - Most treatment decisions were influenced by patient characteristics #ProstateCancer #Urology #CancerResearch tnyp.me/8gdBr54U/x

Post attachment
JU Open Plus avatar
JU Open Plus@JUOpenPlus·Sep 14

🌊 Is D-mannose the Solution for UTIs? Despite mixed findings, D-mannose sparks debate on its role in preventing recurrent UTIs. 🧪 Evidence - Studies show inconclusive efficacy results ⚠️ Caution - Don't dismiss; more research needed 💡 Impact - Can inform personalized medicine approaches #UTI #DMannose #ClinicalResearch

Post attachment